Fatal myositis and myasthenia induced by atezolizumab for the treatment of hepatocellular carcinoma. Dumortier J, Simon M, Bouhour F. Clin Res Hepatol Gastroenterol 2022;46:101854.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dumortier J, Simon M, Bouhour F. Fatal myositis and myasthenia induced by atezolizumab for the treatment of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2022;46:101854.
PMID: 34936927